About Liv
Prostate cancer is increasing day by day, and the latest technological diagnostic methods such as ‘Robotic Prostate Fusion Biopsy’ used at Liv Hospital provide advantages in terms of accurate planning in treatment. With the use of new generation MR - Ultrasound Fusion biopsy devices from the prostate gland, which was previously sampled blindly, targeted biopsy can be performed from suspicious areas. With the introduction of robot technology, the margin of error is minimised in terms of fusion biopsies. Robotic Fusion Prostate Biopsy System is applied at Liv Hospital by the first team using it in Turkey.
Unnecessary Treatment is Prevented
Currently, the diagnostic efficiency of the method accepted as the standard in the diagnosis of prostate cancer is limited. In comparative series with autopsy series, the sensitivity of prostate biopsy is around 50 per cent. Due to this uncertainty, approximately one third of the patients have to undergo biopsy again within 5 years and tumours are detected in 13-41 percent of them. Biopsies with more sampling, which are recommended to overcome these problems, increase the rate of clinically meaningless tumours and thus increase the risk of unnecessary treatment. Targeted sampling with robotic fusion biopsy actually reduces the risk of unnecessary treatment.
Robotic Fusion Prostate Biopsy technology applied at Liv Hospital is one of the most important developments in this field in recent years. The main concept underlying the Prostate Fusion Biopsy technology is to combine the advantages of MR with the advantages of real-time ultrasound imaging by using software recording of two images.
How Is It Applied?
First, MR scans are performed and prostate borders and tumour localisation are determined. This information is then sent electronically to the biopsy department. Three-dimensional ultrasound is performed, although the method varies from device to device. Suspicious areas previously marked on MR images are combined with ultrasound. With the robotic head, a biopsy is performed from the patient's perineum under the guidance of the previously focussed image.
What Are The Advantages?
- It provides more accurate sampling from suspicious areas for prostate cancer and has a low margin of error.
- It provides diagnostic advantage and prevents unnecessary treatment.
- Low risk of infection.
- Does not require hospitalisation.
- Provides advanced imaging technique.